PL3619199T3 - Wytwarzanie pochodnych kwasu 2-([1,2,3]triazol-2-ilo)­-benzoesowego - Google Patents

Wytwarzanie pochodnych kwasu 2-([1,2,3]triazol-2-ilo)­-benzoesowego

Info

Publication number
PL3619199T3
PL3619199T3 PL18722948T PL18722948T PL3619199T3 PL 3619199 T3 PL3619199 T3 PL 3619199T3 PL 18722948 T PL18722948 T PL 18722948T PL 18722948 T PL18722948 T PL 18722948T PL 3619199 T3 PL3619199 T3 PL 3619199T3
Authority
PL
Poland
Prior art keywords
triazol
preparation
benzoic acid
acid derivatives
derivatives
Prior art date
Application number
PL18722948T
Other languages
English (en)
Inventor
Patric DÖRRWÄCHTER
Gunther Schmidt
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of PL3619199T3 publication Critical patent/PL3619199T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/70Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
    • B01J23/72Copper
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL18722948T 2017-05-03 2018-05-02 Wytwarzanie pochodnych kwasu 2-([1,2,3]triazol-2-ilo)­-benzoesowego PL3619199T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2017060451 2017-05-03
PCT/EP2018/061172 WO2018202689A1 (en) 2017-05-03 2018-05-02 Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives
EP18722948.9A EP3619199B1 (en) 2017-05-03 2018-05-02 Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives

Publications (1)

Publication Number Publication Date
PL3619199T3 true PL3619199T3 (pl) 2021-12-20

Family

ID=62116854

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18722948T PL3619199T3 (pl) 2017-05-03 2018-05-02 Wytwarzanie pochodnych kwasu 2-([1,2,3]triazol-2-ilo)­-benzoesowego

Country Status (20)

Country Link
US (1) US11124488B2 (pl)
EP (1) EP3619199B1 (pl)
JP (1) JP7182562B2 (pl)
KR (1) KR102582197B1 (pl)
CN (1) CN110612291B (pl)
CA (1) CA3059394C (pl)
CY (1) CY1124777T1 (pl)
DK (1) DK3619199T3 (pl)
ES (1) ES2892161T3 (pl)
HR (1) HRP20211304T1 (pl)
HU (1) HUE055904T2 (pl)
IL (1) IL270274B (pl)
LT (1) LT3619199T (pl)
MX (1) MX2019012902A (pl)
PL (1) PL3619199T3 (pl)
PT (1) PT3619199T (pl)
RS (1) RS62357B1 (pl)
SI (1) SI3619199T1 (pl)
TW (1) TWI756418B (pl)
WO (1) WO2018202689A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022020924A2 (pt) 2020-04-19 2023-02-14 Idorsia Pharmaceuticals Ltd Métodos de tratamento de um transtorno do sono, a sonolência diurna em um indivíduo, a insônia, e, daridorexante na forma de sal livre ou farmaceuticamente aceitável
TW202400149A (zh) 2022-05-13 2024-01-01 瑞士商愛杜西亞製藥有限公司 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2069332B1 (en) 2006-08-15 2011-03-02 Actelion Pharmaceuticals Ltd. Azetidine compounds as orexin receptor antagonists
ES2350460T3 (es) 2006-09-29 2011-01-24 Actelion Pharmaceuticals Ltd. Derivados de 3-aza-biciclo[3.1.0]hexano.
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
AR064561A1 (es) 2006-12-28 2009-04-08 Actelion Pharmaceuticals Ltd Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
DE602008002934D1 (de) 2007-05-14 2010-11-18 Actelion Pharmaceuticals Ltd 2-cyclopropylthiazolderivate
CA2687230A1 (en) 2007-05-23 2008-12-11 Merck & Co., Inc. Cyclopropyl pyrrolidine orexin receptor antagonists
JP5848251B2 (ja) 2009-10-23 2016-01-27 ヤンセン ファーマシューティカ エヌ.ベー. オレキシン受容体調節因子としての縮合複素環式化合物
EP2491034B1 (en) * 2009-10-23 2013-12-18 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as orexin receptor modulators
JP5759470B2 (ja) 2009-10-23 2015-08-05 ヤンセン ファーマシューティカ エヌ.ベー. オレキシン受容体調節因子としての二置換オクタヒドロピロロ[3,4−c]ピロール
CA2821893A1 (en) 2010-12-17 2012-06-21 Taisho Pharmaceutical Co., Ltd. Pyrazole derivative
WO2012085852A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
US9108959B2 (en) 2011-03-03 2015-08-18 Merck Sharp & Dohme Corp. Process for the preparation of an orexin receptor antagonist
WO2012145581A1 (en) * 2011-04-20 2012-10-26 Janssen Pharmaceutica Nv Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
JPWO2013005755A1 (ja) 2011-07-05 2015-02-23 大正製薬株式会社 メチルピペリジン誘導体
WO2013050938A1 (en) 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
SG11201401665WA (en) 2011-11-08 2014-09-26 Actelion Pharmaceuticals Ltd 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
US9441254B2 (en) 2012-05-09 2016-09-13 Merck Sharp & Dohme Corp. Process for the preparation of an intermediate for an orexin receptor antagonist
CN104334544B (zh) 2012-06-04 2016-10-19 埃科特莱茵药品有限公司 苯并咪唑脯氨酸衍生物
JP2014015452A (ja) 2012-06-15 2014-01-30 Taisho Pharmaceutical Co Ltd ピラゾール誘導体を含有する医薬
EA201500399A1 (ru) * 2012-10-10 2015-09-30 Актелион Фармасьютиклз Лтд. Антагонисты рецептора орексина, которые представляют собой производные [орто-би-(гетеро)арил]-[2-(мета-би-(гетеро)арил)пирролидин-1-ил]метанона
CA2902135A1 (en) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Azetidine amide derivatives as orexin receptor antagonists
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TWI664177B (zh) * 2013-12-03 2019-07-01 瑞士商愛杜西亞製藥有限公司 晶形
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
UA116053C2 (uk) 2013-12-04 2018-01-25 Ідорсія Фармасьютікалз Лтд Застосування похідних бензоімідазолу-проліну
WO2015123355A1 (en) * 2014-02-12 2015-08-20 Eolas Therapeutics, Inc. Substituted prolines / piperidines as orexin receptor antagonists
WO2016020403A1 (en) 2014-08-04 2016-02-11 Sandoz Ag Preparation of a benzoic acid derivative and its use for the preparation of suvorexant
CN104649983B (zh) * 2014-12-23 2018-01-23 广东东阳光药业有限公司 一种酸的制备方法
JP6698633B2 (ja) * 2015-04-24 2020-05-27 武田薬品工業株式会社 複素環化合物

Also Published As

Publication number Publication date
HUE055904T2 (hu) 2021-12-28
RS62357B1 (sr) 2021-10-29
DK3619199T3 (da) 2021-09-27
CY1124777T1 (el) 2022-11-25
JP7182562B2 (ja) 2022-12-02
EP3619199B1 (en) 2021-07-07
TWI756418B (zh) 2022-03-01
IL270274B (en) 2022-08-01
PT3619199T (pt) 2021-10-01
EP3619199A1 (en) 2020-03-11
WO2018202689A1 (en) 2018-11-08
CA3059394C (en) 2023-09-12
ES2892161T3 (es) 2022-02-02
MX2019012902A (es) 2019-12-16
US20210114997A1 (en) 2021-04-22
JP2020518573A (ja) 2020-06-25
LT3619199T (lt) 2021-09-27
CN110612291B (zh) 2024-02-13
CN110612291A (zh) 2019-12-24
CA3059394A1 (en) 2018-11-08
KR102582197B1 (ko) 2023-09-22
HRP20211304T1 (hr) 2021-11-12
US11124488B2 (en) 2021-09-21
KR20200003097A (ko) 2020-01-08
IL270274A (pl) 2019-12-31
TW201843144A (zh) 2018-12-16
SI3619199T1 (sl) 2021-11-30

Similar Documents

Publication Publication Date Title
EP3402787A4 (en) PROCESSES FOR PREPARING 2,5-FURANDICARBOXYLIC ACID AND INTERMEDIATES AND DERIVATIVES THEREOF
HUE065368T2 (hu) Eljárás 2,5-furándikabonsav és származékai elõállítására
EP3370728A4 (en) PROCESS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF
EP3480198A4 (en) NEW COMPOUND OR ITS PHARMACEUTICALLY ACCEPTED SALT
EP3679945A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITION
IL260011A (en) History of 5,3-diphenyl-diazole water-soluble compounds
IL271399A (en) Methods for the preparation of heterocyclic 3,1-benzodioxole compounds
EP3384772A4 (en) AGROCHEMICAL COMPOSITION IN AQUEOUS SUSPENSION
EP3315492A4 (en) Pyrazole derivative, or pharmaceutically acceptable salt thereof
EP3490978A4 (en) SALTS OF 2, 6-DIMETHYLPYRIMIDONE DERIVATIVES AND THEIR USES
EP3445370A4 (en) PROCESSES FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF
EP3442943A4 (en) AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND / OR ANTICANCER AGENTS
MX2018007415A (es) Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
PL3619199T3 (pl) Wytwarzanie pochodnych kwasu 2-([1,2,3]triazol-2-ilo)­-benzoesowego
IL259556A (en) Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds
EP3530654A4 (en) CARBOXYLIC ACID COMPOUND WITH QUINOLINYL SUBSTITUTE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3189842A4 (en) Composition for preventing hair loss or promoting hair growth, containing oleanolic acid derivative and pharmaceutically acceptable salt thereof
HK1258757A1 (zh) 4H-吡唑並[1,5-α]苯並咪唑類化合物的鹽型、晶型及其製備方法和中間體
EP3699250A4 (en) COMPOSITION PROVIDING A FRESHNESS FEELING CONTAINING A DERIVATIVE OF 2,2,6-TRIMETHYLCYLCYCLOHEXANECARBOXYLIC ACID
IL254578A0 (en) Abscisic acid (s)-2' vinyl derivatives
EP3398946A4 (en) SALT OF MORPHOLINE DERIVATIVE AND ITS CRYSTALLINE FORM, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3436439A4 (en) METHOD FOR PRODUCING DIPHENYLPYRAZINE DERIVATIVES
EP3166405A4 (en) 3'-substituted-abscisic acid derivatives
EP3856732C0 (en) PROCESS AND SALTS FOR THE PREPARATION OF 2,5-FURANEDICARBOXYLIC ACID
EP3177592A4 (en) Process for the preparation of 4,5,6-trichloropicolinic acid